Indicators

Markets:

News

Latest News about ALLO

Recent news which mentions ALLO

< Previous 1 2 3 4 5 Next >

Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022

December 12, 2022

Precigen's Overnight Cell Manufacturing Technology Could Offer Advanced AML Patients The Option Of Promising CAR-T Therapy

December 08, 2022

Expert Ratings for Allogene Therapeutics

September 22, 2022

Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday

September 22, 2022

Apple, Amazon, HP And Other Big Losers From Friday

August 29, 2022

Why Everbridge Jumped Over 17%; Here Are 90 Biggest Movers From Friday

August 29, 2022

What 5 Analyst Ratings Have To Say About Allogene Therapeutics

August 10, 2022

Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2022

August 10, 2022

Allogene Therapeutics: Q2 Earnings Insights

August 09, 2022

Why Beam Therapeutics Stock Dipped Today

August 01, 2022

Beyond Meat, Canoo, Veru And More: 12 Short Squeeze Candidates To Watch

July 20, 2022

Benzinga's Top Ratings Upgrades, Downgrades For July 15, 2022

July 15, 2022

12 Health Care Stocks Moving In Friday's Pre-Market Session

July 15, 2022

89 Biggest Movers From Friday

June 21, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2022

June 03, 2022

What 4 Analyst Ratings Have To Say About Allogene Therapeutics

June 03, 2022

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

May 17, 2022

Why This Analyst Has 'Little Conviction' On CRISPR's Upcoming Trial Data

May 10, 2022

The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints

May 04, 2022

U.S. FDA Grants Orphan-Drug Designation for Allogene's ALLO-605 for multiple myeloma

April 27, 2022

The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis

April 27, 2022

Allogene's Preclinical Data Show Healthy Donor-Derived Allogeneic CAR T Cells Have Better Immune Fitness, Killing Activity

March 23, 2022

Why Cellectis Stock Rose 20.7% This Week

March 10, 2022

Recap: Allogene Therapeutics Q4 Earnings

February 23, 2022

Allogene Therapeutics Earnings Preview

February 22, 2022

Stocks That Hit 52-Week Lows On Wednesday

February 16, 2022

FDA Lifts Clinical Hold On Allogene's CAR-T Trials

January 11, 2022

12 Health Care Stocks Moving In Monday's Pre-Market Session

December 20, 2021

58 Biggest Movers From Yesterday

December 14, 2021

12 Health Care Stocks Moving In Monday's Intraday Session

December 13, 2021

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.